Abiomed, Inc. (ABMD) Reports Q1 Loss of $0.04/Share
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Revenue Growth %: -100.0%
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Revenue Growth %: -100.0%
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Join SI Premium – FREE
Abiomed, Inc. (NASDAQ: ABMD) reported Q1 EPS of ($0.04), versus ($0.04) reported last year. Revenue for the quarter came in at $48.8 million versus the consensus estimate of $297.1 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Amerant Bancorp Inc. (AMTB) Misses Q1 EPS by 5c
- FS Bancorp (FSBW) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
